Citation: Tr. Klumpp et al., Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial - Reply, TRANSFUSION, 40(3), 2000, pp. 384-384
Citation: Sj. Ackerman et al., Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial, TRANSFUSION, 40(12), 2000, pp. 1457-1462
Citation: Mh. Goodstein et al., Metabolic consequences in very low birth weight infants transfused with older AS-1-preserved erythrocytes, PEDIAT PATH, 18(2), 1999, pp. 173-185
Citation: La. Chambers et Jh. Herman, Considerations in the selection of a platelet component: Apheresis versus whole blood-derived, TR MED REV, 13(4), 1999, pp. 311-322
Citation: Tr. Klumpp et al., Clinical consequences of alterations in platelet transfusion dose: a prospective, randomized, double-blind trial, TRANSFUSION, 39(7), 1999, pp. 674-681